Boyeong Song

Title: Boyeong Song and Cancer Immunotherapy Innovation.

Introduction

Boyeong Song is an inventor associated with Seoul, South Korea, and Cell Id Pte Ltd. His reported patent work concerns an experimental vaccine approach that uses natural killer cells to support immune responses against cancer.

Latest Patents

Song is associated with 1 patent: “Vaccine comprising natural killer cells loaded with ligands of natural killer T cells and cancer antigens.” The invention describes an immunotherapeutic or preventive vaccine using natural killer cells loaded with cancer antigens and natural killer T-cell ligands, including alpha-galactosylceramide (α-GC), a glycolipid.

The patent’s description proposes that these loaded natural killer cells could help induce cytotoxic T-lymphocyte responses and produce therapeutic effects against malignant tumors. It also presents natural killer cells as a potentially more accessible alternative to dendritic cells for preparing this type of vaccine.

Career Highlights

Song’s listed patent connects his work with cancer immunotherapy and vaccine development. The invention focuses on combining immune-cell loading with tumor antigens and natural killer T-cell ligands to stimulate antitumor responses.

Collaborations

Song’s listed coworkers include Chang-Yuil Kang and Insu Jeon. The available information identifies these professional associations but does not specify their individual contributions to the patent.

Conclusion

Boyeong Song’s reported invention explores a natural-killer-cell-based vaccine strategy intended to strengthen immune responses against cancer. His patent work reflects an effort to develop alternative approaches to cancer immunotherapy.